Sort by
Refine Your Search
-
ONLY About Us The antibody discovery group wishes to appoint a Postdoctoral Research Assistant with knowledge of cancer immunology and experience in cell-based cancer, immunological or antibody
-
the Leukaemia and Stem Cell Biology Group. The post-holder will be expected to demonstrate a flexible and dedicated approach to their work. About the role This is a research post aiming to assist Professor So in
-
modelling, specifically focusing on thermal runaway and cell-to-cell propagation of flaming combustion. The role-holder will be part of a larger team on the SAFEBATT Project, major grant of the faraday
-
University of London. About the role We are looking for a skilled postdoctoral researcher with a strong background in molecular biology, cell biology, genetics or development. The project will investigate
-
differentiation and disease. Ideal candidates should have excellent skills in human pluripotent stem cell culture or mouse genetics/surgery, such as MI and TAC, as well as techniques such as CRISPR/Cas9 genome
-
project will focus on understanding sex differences in a mouse model of beta cell endoplasmic reticulum stress. The post holder will use a wide range of in vitro and in vivo techniques including small
-
of condensed matter, theoretical particle physics and cosmology; and experimental particle and astroparticle physics. About the role We are seeking to appoint a biophysicist or a cell/molecular biologist
-
Applications are invited for a four-year Research Assistant position working on a project funded by the Steve Morgan Foundation entitled ‘Towards translation: improving the functional survival of stem cell
-
Therapy & Regenerative Medicine (CGTRM), in partnership with KCL Gene Therapy Vector Facility (GTVF), manufactures ATMPs for a wide variety of novel gene and cell therapies for the treatment of cancers
-
designed to detect tumour cell death (2 days/week). The aim of the second project is to use molecular imaging to better-understand the role of intracellular antioxidants in drug-resistant cancer (2 days/week